C

Celularity, Inc.

247 employees

Celularity is a clinical-stage biotechnology company developing off-the-shelf placental-derived allogeneic cell therapies.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
Health Care
Therapeutics
Wellness

Date founded

2016

Funding rounds raised

Total raised

$250M

from 9 investors over 9 rounds

C

Celularity, Inc. raised $80M on July 19, 2021

Investors: Sorrento Therapeutics, Inc.

C

Celularity, Inc. raised $250M on February 15, 2018

Investors: Section 32, Sorrento Therapeutics, Inc., United Therapeutics Corporation, Human Longevity, Inc., Heritage Group and Celgene

C

Celularity, Inc. raised $40M on September 28, 2017

Investors: Castor Ventures and Alumni Ventures Group

FAQ